Skip to content

NEVRO CORP.

CIK 0001444380

← back to feed
Revenue (TTM)
$406.83M
−3.9% YoY FY Feb 2025
Net Income (TTM)
−$83.81M
−23.0% YoY FY Feb 2025
EPS Diluted (TTM)
−$2.29
−19.5% YoY FY Feb 2025
Gross Margin
67.1%
FY Feb 2025
Operating Margin
-24.7%
FY Feb 2025
Net Margin
-20.6%
FY Feb 2025
Free Cash Flow (TTM)
−$106.8M
FY Feb 2025
Cash
$94.54M
FY Feb 2025
Total Debt
$225.64M
FY Feb 2025
Shares Outstanding
37.88M sh
FY Feb 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings